Raytheon Technologies Other Income (Expense) increased by 88.3% to -$35.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 54.5%, from -$77.00M to -$35.00M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 114.1% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$148.00M | -$133.00M | $453.00M | -$162.00M | -$145.00M | -$157.00M | -$149.00M | -$129.00M | -$114.00M | -$74.00M | $592.00M | -$19.00M | -$101.00M | -$122.00M | -$102.00M | -$77.00M | -$106.00M | -$85.00M | -$299.00M | -$35.00M |
| QoQ Change | — | +10.1% | +440.6% | -135.8% | +10.5% | -8.3% | +5.1% | +13.4% | +11.6% | +35.1% | +900.0% | -103.2% | -431.6% | -20.8% | +16.4% | +24.5% | -37.7% | +19.8% | -251.8% | +88.3% |
| YoY Change | — | — | — | — | +2.0% | -18.0% | -132.9% | +20.4% | +21.4% | +52.9% | +497.3% | +85.3% | +11.4% | -64.9% | -117.2% | -305.3% | -5.0% | +30.3% | -193.1% | +54.5% |